The Efficacy and Safety of Liraglutide Adjunct to Insulin Treatment in Type 1 Diabetes

NCT02098395 · clinicaltrials.gov ↗

PHASE3

Phase

COMPLETED

Status

835

Enrollment

INDUSTRY

Sponsor class

Conditions

Diabetes
Diabetes Mellitus, Type 1

Interventions

DRUG: liraglutide
DRUG: liraglutide
DRUG: liraglutide
DRUG: placebo
DRUG: placebo
DRUG: placebo

Sponsor

Novo Nordisk A/S